Contact
searchSearch
HMP Global

Volume 34 - Issue 5 - May, 2022

May 2022 Table of Contents
05/01/2022
May 2022 Table of Contents and Whole Issue PDF
May 2022 Table of Contents and Whole Issue PDF
May 2022 Table of Contents and...
05/01/2022
Journal of Invasive Cardiology
Original Contribution
Transcatheter Aortic Valve Replacement for Severe Aortic Regurgitation in Patients With a Left Ventricular Assist Device
05/01/2022
Ashwat S. Dhillon, MD; Brandon M. Jones, MD; Robert W. Hodson, MD; Ethan C. Korngold, MD
There are limited invasive treatment options for patients with end-stage heart failure and left ventricular assist device (LVAD) who develop severe aortic valve regurgitation (AR). One option for such patients is transcatheter aortic valve...
There are limited invasive treatment options for patients with end-stage heart failure and left ventricular assist device (LVAD) who develop severe aortic valve regurgitation (AR). One option for such patients is transcatheter aortic valve...
There are limited invasive...
05/01/2022
Journal of Invasive Cardiology

Feature

Original Contribution
True Efficacy of LAA Closure: Patient Outcomes on Long-term Single-Antiplatelet or No Therapy: Insights From the EWOLUTION Registry
05/01/2022
Aleksandr Romanov, MD; Thomas Schmitz, MD; Boris Schmidt, MD; Tommaso Gori, MD; Alexey Vladimir Protopopov, MD, PhD; Timothy Betts, MD; Elisa Vireca; Lucas Boersma, MD, PhD; Peter Wohlmuth; Christina Paitazoglou, MD; Felix Meincke, MD; Martin W. Bergmann, MD, PhD; Hüseyin Ince, MD, PhD; Stephan Kische, MD
Left atrial appendage occlusion (LAAO) is recommended for patients with atrial fibrillation at increased stroke risk, where effective long-term oral anticoagulation (OAC) is not feasible. In order to assess long-term safety of LAAO with...
Left atrial appendage occlusion (LAAO) is recommended for patients with atrial fibrillation at increased stroke risk, where effective long-term oral anticoagulation (OAC) is not feasible. In order to assess long-term safety of LAAO with...
Left atrial appendage occlusion...
05/01/2022
Journal of Invasive Cardiology
Original Contribution
Outcomes of Radial Versus Femoral Access in Patients With Severe Aortic Stenosis Undergoing Percutaneous Coronary Intervention Prior to Transcatheter Aortic Valve Replacement
05/01/2022
Charanjit S. Rihal, MD, MBA, FSCAI; Abdallah El Sabbagh, MD; Mohammed A. Al-Hijji, MD; Mackram F. Eleid, MD; Mohammed Al-Khouli, MD; Salman Farhat, MBBS; Yader Sandoval, MD; Keniel Pierre, MD; Malcolm R. Bell, MD; Nahyr S. Lugo-Fagundo, MD; Rajiv Gulati, MD, PhD; Michael S. Gharacholou, MD; Mayra Guerrero, MD; Peter M. Pollak, MD; David R. Holmes, Jr., MD; Mandeep Singh Randhawa, MD
This study included consecutive patients who underwent PCI within 30 days before TAVR at Mayo Clinic. Vascular access was left to the discretion of the operator. Baseline demographics, procedural data, PCI outcomes, and subsequent...
This study included consecutive patients who underwent PCI within 30 days before TAVR at Mayo Clinic. Vascular access was left to the discretion of the operator. Baseline demographics, procedural data, PCI outcomes, and subsequent...
This study included consecutive...
05/01/2022
Journal of Invasive Cardiology
Original Contribution
Clinical Outcomes in Patients Treated With Biodegradable-Polymer Biolimus-Eluting Stents and 6 Months of Dual-Antiplatelet Therapy: The French eBiomatrix 6-Month DAPT Registry
05/01/2022
Antoine Gommeaux, MD; Vincent Malquarti, MD; Denis Angoulvant, MD; Clauset Cruchon, MD; Keith G. Oldroyd, MD, MBChB, FRCP; Christian Spaulding, MD; Hakim Benamer, MD; Thierry Lefèvre, MD; Olivier Varenne, MD; Janusz Lipiecki, MD; Rajiv Rampat, MD; Christophe Piot, MD; François Brunelle, MD; Rami el Mahmoud, MD
Dual-antiplatelet treatment (DAPT) has conventionally been prescribed for 1 year after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation. Recent evidence suggests that a duration of only 6 months may be...
Dual-antiplatelet treatment (DAPT) has conventionally been prescribed for 1 year after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation. Recent evidence suggests that a duration of only 6 months may be...
Dual-antiplatelet treatment...
05/01/2022
Journal of Invasive Cardiology
Original Contribution
Invasive Hemodynamics in Asymptomatic Adult Fontan Patients and According to Different Clinical Phenotypes
05/01/2022
Donald J. Hagler, MD; Alexander C. Egbe, MBBS, MPH, MD, MS; William R. Miranda, MD; Heidi M. Connolly, MD; Patrick S. Kamath, MD
The correlation between hemodynamics and clinical phenotypes/symptoms in adults post Fontan procedure has not been well studied. Moreover, the “expected” hemodynamics in those who are asymptomatic remain unclear.
The correlation between hemodynamics and clinical phenotypes/symptoms in adults post Fontan procedure has not been well studied. Moreover, the “expected” hemodynamics in those who are asymptomatic remain unclear.
The correlation between...
05/01/2022
Journal of Invasive Cardiology
Original Contribution
Reframing Optimal Implantation of the Sapien 3 Transcatheter Heart Valve
05/01/2022
Paul F. Brennan, MD, FRCP; Aileen Kearney, MBChB, FRCP; Meadhbh C. Hogg, MBChB; Andrew H. McNeice, MBChB, FRCP; Reuben Jeganathan, MD, FRCS; Mark S. Spence, MD, FRCP; Ganesh Manoharan, MD, FRCP; Colum G. Owens, MD, FRCP; Jonathan A. Mailey, MBChB, FRCP
This was an observational study of 279 patients treated with the Sapien 3 THV. Fluoroscopic imaging was used to categorize patients into low (n = 147), intermediate (n = 86), and high (n = 46) implantation zones. These zones were based on the...
This was an observational study of 279 patients treated with the Sapien 3 THV. Fluoroscopic imaging was used to categorize patients into low (n = 147), intermediate (n = 86), and high (n = 46) implantation zones. These zones were based on the...
This was an observational study...
05/01/2022
Journal of Invasive Cardiology
Original Contribution
Accuracy and Potential Benefit of Ultraselective Invasive Coronary Angiography Guided by Computed Tomographic Coronary Angiography
05/01/2022
Marcel van't Veer, PhD; Sjoerd Bouwmeester, MD; Luuk C. Otterspoor, MD, PhD; Pim A. L. Tonino, MD, PhD; Jeroen Lammers, MD; Mark Winkens, MD, PhD; Lokien X. van Nunen, MD, PhD; Konrad A. J. van Beek, BSc; Anouk G. W. de Lepper, MD
It is unknown whether computed tomographic coronary angiography (CTCA) can be used to perform ultraselective invasive coronary angiography (ICA) by only visualizing the abnormal coronary artery on CTCA and defer visualization of the normal...
It is unknown whether computed tomographic coronary angiography (CTCA) can be used to perform ultraselective invasive coronary angiography (ICA) by only visualizing the abnormal coronary artery on CTCA and defer visualization of the normal...
It is unknown whether computed...
05/01/2022
Journal of Invasive Cardiology
Original Contribution
Proximal to Distal Y-Stent Deployment for Coronary Bifurcation Lesions: Procedure and Three-Year Clinical Outcomes
05/01/2022
John A. Ormiston, MB, MD, MBChB; Mark W.I. Webster, MD, MBChB; Patricia Ying Jia Ding, MBChB; Sudhakar George, MD; Bruce Webber, BSc(Hons); Eliazar Dimalapang
Percutaneous coronary intervention with Y-stenting of coronary bifurcation disease is not commonly undertaken. The procedural and medium-term clinical outcomes of coronary bifurcation lesions treated with the proximal to distal Y stent...
Percutaneous coronary intervention with Y-stenting of coronary bifurcation disease is not commonly undertaken. The procedural and medium-term clinical outcomes of coronary bifurcation lesions treated with the proximal to distal Y stent...
Percutaneous coronary...
05/01/2022
Journal of Invasive Cardiology
Brief Communication
Use of a Novel Catheter, the MOT-C, for Selective Angiography of the Internal Mammary Artery From Ipsilateral Radial Access
05/01/2022
Steffne Kunnirickal, MD; Steven Pfau, MD; Edward Moran, RT(R); Samit Shah, MD, PhD, FACC, FSCAI
We describe a novel catheter, the MOT-C (Merit Medical Systems), for selective diagnostic angiography of the internal mammary artery from radial access.
We describe a novel catheter, the MOT-C (Merit Medical Systems), for selective diagnostic angiography of the internal mammary artery from radial access.
We describe a novel catheter,...
05/01/2022
Journal of Invasive Cardiology

News

Intravascular Imaging
ECLIPSE Trial: Intravascular Imaging Can Improve Outcomes for Complex Stenting Procedures in Patients with High-Risk Calcified CAD
03/31/2025
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that...
03/31/2025
Cath Lab Digest
Aortic Stenosis
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
03/31/2025
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the...
03/31/2025
Cath Lab Digest
CAD in Women
New Intermountain Health Study Finds Gap Between Heart Disease Outcomes in Men and Women Has Narrowed Over Past 20 Years  
03/31/2025
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older...
03/31/2025
Cath Lab Digest
AI
HeartFocus Clinical Trial Proves AI Can Empower Novices to Deliver Diagnostic-Quality Cardiac Ultrasounds
03/31/2025
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of...
03/31/2025
Cath Lab Digest
plaque analysis
CONFIRM2 Registry: Late-Breaking Clinical Trial Results Demonstrate the Predictive Power of Cleerly's AI-QCT for Women’s Cardiovascular Risk at ACC.25
03/31/2025
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that...
03/31/2025
Cath Lab Digest
Statins
CorCal Outcomes Study: Who Needs a Statin? Intermountain Study Compares Prescribing Recommendations Based on Traditional Risk Factors vs. Coronary Artery Calcium Scoring
03/31/2025
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal...
03/31/2025
Cath Lab Digest
CardiAMP Procedure
Cell Therapy
BioCardia Phase 3 CARDIAMP-HF Trial of Novel Cardiac Cell Therapy for Ischemic Heart Failure Shows Increased Survival, Decreased Cardiac Events, and Improved Quality of Life at Two Years
03/31/2025
"In this rigorous CardiAMP-HF Trial, patients who received the novel cell therapy adjunctive to medication experienced decreased mortality and MACCE, with improved quality of life, when compared to those on medication alone," said...
"In this rigorous CardiAMP-HF Trial, patients who received the novel cell therapy adjunctive to medication experienced decreased mortality and MACCE, with improved quality of life, when compared to those on medication alone," said...
"In this rigorous CardiAMP-HF...
03/31/2025
Cath Lab Digest
Peripheral Arterial Disease
New Study Finds Peripheral Artery Disease Often Underdiagnosed and Undertreated; Opportunity to Improve Treatments and Lower Death Rates
03/31/2025
Researchers identified 7,522 patients who had a symptomatic peripheral artery disease diagnosis at Intermountain Health facilities between January 2006 and December 2021 and were seen once in follow-up within at least 18 months of their...
Researchers identified 7,522 patients who had a symptomatic peripheral artery disease diagnosis at Intermountain Health facilities between January 2006 and December 2021 and were seen once in follow-up within at least 18 months of their...
Researchers identified 7,522...
03/31/2025
Cath Lab Digest
TAVR
Evolut Low Risk Trial: Medtronic Evolut TAVR System Shows Durable Clinical Outcomes and Outstanding Valve Performance at 5 Years in Low-Risk AS Patients
03/31/2025
"Results at five years support Evolut's supra-annular, self-expanding TAVR as a safe, effective, and durable alternative to surgery for patients with severe aortic stenosis, regardless of their surgical risk," said Michael J. Reardon, MD.
"Results at five years support Evolut's supra-annular, self-expanding TAVR as a safe, effective, and durable alternative to surgery for patients with severe aortic stenosis, regardless of their surgical risk," said Michael J. Reardon, MD.
"Results at five years support...
03/31/2025
Cath Lab Digest
Calcium Score
Low Coronary Artery Calcium Score is Associated with An Excellent Prognosis Regardless of a Person’s Age, New Intermountain Health Study Finds
03/31/2025
“We found that a zero-plaque burden is not only highly prognostic of good heart health at any age, but also of excellent overall survival,” said Jeffrey L. Anderson, MD, principal investigator of the study.
“We found that a zero-plaque burden is not only highly prognostic of good heart health at any age, but also of excellent overall survival,” said Jeffrey L. Anderson, MD, principal investigator of the study.
“We found that a zero-plaque...
03/31/2025
Cath Lab Digest

CRT Conference Coverage
Disparities in Interventional Cardiology
04/02/2025
Laura Simson
At the Sunday afternoon "Disparities in Interventional Cardiology" session at CRT 2025, experts presented compelling data and discussed the barriers that limit diverse representation in the field, ranging from clinical trials and...
At the Sunday afternoon "Disparities in Interventional Cardiology" session at CRT 2025, experts presented compelling data and discussed the barriers that limit diverse representation in the field, ranging from clinical trials and...
At the Sunday afternoon...
04/02/2025
Journal of Invasive Cardiology
CRT Conference Coverage
Artificial Intelligence in Coronary Artery Disease Diagnosis and Intervention
04/02/2025
Laura Simson
In his Sunday morning session and ensuing panel discussion at CRT 2025, Dr Ran Kornowski of the Rabin Medical Center in Petach-Tikva, Israel, detailed how AI is transforming clinical practice and research in interventional cardiology.
In his Sunday morning session and ensuing panel discussion at CRT 2025, Dr Ran Kornowski of the Rabin Medical Center in Petach-Tikva, Israel, detailed how AI is transforming clinical practice and research in interventional cardiology.
In his Sunday morning session...
04/02/2025
Journal of Invasive Cardiology
Original Contribution
Polidocanol Ablation in Midventricular Obstructive Cardiomyopathy: Novel Approach and Early Outcomes
04/01/2025
Limited data exist regarding polidocanol use for septal ablation, particularly in the context of midventricular obstruction (MVO) . This study presents the first reported use of polidocanol for septal ablation in patients with MVO.
Limited data exist regarding polidocanol use for septal ablation, particularly in the context of midventricular obstruction (MVO) . This study presents the first reported use of polidocanol for septal ablation in patients with MVO.
Limited data exist regarding...
04/01/2025
Journal of Invasive Cardiology
Original Contribution
Heart Rate Variability of Interventional Cardiology Fellows and Attendings and Changes Over Time
04/01/2025
The study examined the stress levels of interventional cardiology (IC) fellows and attendings using both objective (heart rate variability) and subjective (State Trait Anxiety Inventory) metrics across the IC fellowship.
The study examined the stress levels of interventional cardiology (IC) fellows and attendings using both objective (heart rate variability) and subjective (State Trait Anxiety Inventory) metrics across the IC fellowship.
The study examined the stress...
04/01/2025
Journal of Invasive Cardiology
Intravascular Imaging
ECLIPSE Trial: Intravascular Imaging Can Improve Outcomes for Complex Stenting Procedures in Patients with High-Risk Calcified CAD
03/31/2025
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that...
03/31/2025
Cath Lab Digest
Aortic Stenosis
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
03/31/2025
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the...
03/31/2025
Cath Lab Digest
CAD in Women
New Intermountain Health Study Finds Gap Between Heart Disease Outcomes in Men and Women Has Narrowed Over Past 20 Years  
03/31/2025
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older...
03/31/2025
Cath Lab Digest
AI
HeartFocus Clinical Trial Proves AI Can Empower Novices to Deliver Diagnostic-Quality Cardiac Ultrasounds
03/31/2025
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of...
03/31/2025
Cath Lab Digest
plaque analysis
CONFIRM2 Registry: Late-Breaking Clinical Trial Results Demonstrate the Predictive Power of Cleerly's AI-QCT for Women’s Cardiovascular Risk at ACC.25
03/31/2025
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that...
03/31/2025
Cath Lab Digest
Statins
CorCal Outcomes Study: Who Needs a Statin? Intermountain Study Compares Prescribing Recommendations Based on Traditional Risk Factors vs. Coronary Artery Calcium Scoring
03/31/2025
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal...
03/31/2025
Cath Lab Digest

May 2022 Volume 34 Issue 5

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use